Clearside Biomedical, Inc. — Director's Dealing 2019

Sep 20, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clearside Biomedical, Inc. (CLSD)
CIK: 0001539029
Period of Report: 2019-09-18

Reporting Person: Deignan Charles A. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-18	Common Stock	A	70000	$0.00	Acquired	196356	Direct

Footnotes

F1: These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. On September 18, 2020, 50% of the shares underlying this restricted stock unit award will vest, and the remaining shares underlying this restricted stock unit award will vest quarterly thereafter over four quarters, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.